Palliative care for glioblastoma (GBM) can last from days to many months, but hospice (end-of-life palliative care) often averages around one month, with some studies showing a median of about 21-24 days before death, though it varies greatly depending on disease progression and when care starts. Palliative care itself can begin early in the diagnosis, focusing on symptom management and quality of life, potentially for years, while hospice care intensifies as death nears, typically when life expectancy is considered six months or less.
Despite multimodal treatment, gliomas are nearly always incurable. Sooner or later, tumor-directed treatment will be no longer effective and the patient's condition will decline. This is where the end-of-life (EOL) phase starts, which is generally confined to the last 3 months before death.
It seems that most brain tumor patients tend to average 1 month or so under hospice care, though the disease may have been progressing well before that time.
We support patients and their families through this tough time. The glioblastoma hospice timeline usually lasts from weeks to months. On average, patients spend about a month in hospice care. Knowing this journey is key to understanding end-of-life care.
Palliative care aims to improve the quality of life for people and their families by addressing their physical, psychosocial, and spiritual needs. The prevalence of GBM peaks between 65 and 84 years of age, and treatment options may be hindered by chronic multiple conditions in older people.
Signs of approaching death from glioblastoma involve increased drowsiness, confusion (delirium), difficulty swallowing (dysphagia), changes in breathing (like pauses or shallow breaths), loss of appetite, and eventual loss of bladder/bowel control, as the body's functions slow down, leading to weakness and less responsiveness. Patients may also experience restlessness, agitation, hallucinations, or moments of unusual clarity, with breathing becoming more shallow or relying on abdominal muscles.
If treatments are ineffective, the patient's health is quickly worsening, or the patient or family chooses to give comfort top priority over treatment, hospice care is a suitable alternative.
Glioblastoma symptoms may include headaches that keep getting worse, nausea and vomiting, blurred or double vision, trouble speaking, altered sense of touch, and seizures. There also may be trouble with balance, coordination, and moving parts of the face or body.
Avoid talking in an overly optimistic way, for example, “You'll be up in no time”. Such comments block the possibility of discussing how they're really feeling – their anger, fears, faith etc. Apologise if you think you've said the wrong thing. Let them know if you feel uncomfortable.
Caring For Someone with Brain Cancer
Recognizing the transition: When active dying begins
The transition into active dying typically begins when a person stops eating and drinking, becomes mostly unresponsive, and shows significant physical decline. Breathing patterns may shift dramatically—pausing for long intervals or becoming more rapid and shallow.
In some cases, death may be preceded by a few hours or days in which the patient has noticeable signs and symptoms. Though death itself comes quickly, it's important to understand that death from glioblastoma often results from a gradual process of physical decline.
How to support someone with a brain tumour
Without treatment, glioblastoma progresses very rapidly, leading to significant symptoms in a matter of weeks to a few months.
Changes in breathing
You may notice a change in your loved one's breathing pattern. It may become slower, less regular and shallower. Or it could become deeper and more rapid. If your loved one is anxious or agitated, or if their tumour is in the brain stem, they may breathe faster and become breathless.
Glioblastoma patients with blood vitamin D levels greater than 30 ng/mL prior to initiation of chemotherapy and radiation have longer overall survival [65], and those who reported vitamin D use after diagnosis of glioblastoma have been reported to have a survival advantage [45].
The 80/20 rule is part of the Medicare hospice rule that ensures most hospice services are delivered where patients feel most comfortable — at home. Under this guideline, at least 80% of all hospice care must be provided in a patient's home setting, such as a private residence, assisted living, or nursing facility.
The “three magic phrases”—you will not be alone, you will not feel pain, we will be okay—struck a chord with me not only as someone who has sat beside dying friends, but as someone who has wondered what I would want to hear if it were me.
Key signs 2 weeks before death at the end-of-life stages timeline: Extreme fatigue and increased sleep. A marked decrease in appetite and fluid intake. Irregular breathing patterns (Cheyne-Stokes breathing)
In 40% of the patients, incontinence was reported to occur before the patients were bed-ridden. Headache, progressive cognitive deficits (memory loss, personality changes, apathy, and problems in executive functioning and understanding), and agitation/confusion all were reported in one-third of the patients.
Risk factors of glioblastoma
Exposure to chemicals, like pesticides, petroleum, synthetic rubber and vinyl chloride. Genetic, tumor-causing conditions, like neurofibromatosis, Li-Fraumeni syndrome and Turcot syndrome. Previous radiation therapy to your head.
The average life expectancy for glioblastoma patients who undergo treatment is 12-15 months and only four months for those who do not receive treatment. Nearly 28% of brain and central nervous system (CNS) tumors are malignant, and nearly 50% of those malignant tumors are Glioblastoma.
How often do I get Avastin infusions? Avastin is given every 2 weeks to treat your recurrent glioblastoma.
For glioblastoma, radiation is still the most effective therapy. But radiation exposure also is the only known risk factor for its development, and could perhaps also drive recurrence.
Patients undergoing chemotherapy are administered special drugs designed to kill tumor cells. Chemotherapy with the drug temozolomide is the current standard of treatment for GBM. The drug is generally administered every day during radiation therapy and then for six cycles after radiation during the maintenance phase.